Tilray TLRY Stock Analysis and why TLRY stock is plummeting – what’s next for TLRY stock

Pharmalittle: We’re reading about a thumbs down for an Alzheimer’s drug, Pfizer gene therapy struggles, and more

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

July 26, 2024

6 Ways AI is Reshaping Healthcare Diagnostics & Treatment

Raman Parthasarathy, Business Unit Head, Fusemachines Of the many industries witnessing AI-led transformation, healthcare happens to be one. Today, AI’s promise in healthcare extends beyond

June 21, 2024

GSK pulls plans to market anemia drug in EU and other markets, citing ‘reduced opportunity’

It appears GSK’s Jesduvroq will not launch in new markets for now, with the pharma giant withdrawing its bid to market the anemia drug in

July 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.